Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease.
Francesca
F
Cortini
Chiara
C
Fenoglio
Eliana
E
Venturelli
Chiara
C
Villa
Francesca
F
Clerici
Maria
M
Serpente
Claudia
C
Cantoni
Giorgio
G
Fumagalli
Claudio
C
Mariani
Nereo
N
Bresolin
Elio
E
Scarpini
Daniela
D
Galimberti
D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics*; D053327:Apolipoprotein E4 / Q000235:genetics; D016001:Confidence Intervals; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics*; D004252:DNA Mutational Analysis; D003952:Diagnostic Imaging / Q000379:methods; D005260:Female; D005787:Gene Frequency; D014644:Genetic Variation / Q000235:genetics*; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D016017:Odds Ratio; D011569:Psychiatric Status Rating Scales
D053327:Apolipoprotein E4; C493966:CDKN2B protein, human; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16